GILD
2025Q1AMCGilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS1.78
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move2.0%
IV front—
P/C full—
P/C front—
Features as of2025-04-24
Run-up
Close—
Ret 5d+1.2%
Ret 10d+0.9%
Ret 20d-2.9%
Ret 30d-6.9%
Actual EPS
1.81Beat
Estimated EPS1.78
Actual revenue
6.7B
Surprise %+1.7%
Beat / missBeat
Beat streak 44
Beat streak 85
Reaction
1-day stock reaction+0.5%
Implied vs actual
Implied 2.0%Actual 3.3%
Gap reaction-3.3%
Day result-2.8%
Next-day upYes
Realized / IV1.62×
Post tape
Post 5d+0.5%
Post 10d-6.1%
Post volume14.2M
Vol ×10d1.68×
Vol ×20d1.50×
Post range10.5%